Trine Heide Øllegaard

The real-world impact of modern treatments on the survival of patients with metastatic melanoma

Marco Donia, Trine Heide Øllegaard, Lone Duval et al. · European Journal of Cancer · 2018 · 63 citations

Oncology, Cancer Management, Melanoma +8

Innate immune cell infiltration in melanoma metastases affects survival and is associated with BRAFV600E mutation status

Nina Dabrosin, Karen Sloth Juul, Jeanette Bæhr Georgsen et al. · Melanoma Research · 2018 · 26 citations

Inflammatory Cytokines and ctDNA Are Biomarkers for Progression in Advanced-Stage Melanoma Patients Receiving Checkpoint Inhibitors

Jesper G Pedersen, Anne Tranberg Madsen, Kristine Raaby Gammelgaard et al. · Cancers · 2020 · 25 citations · Full text

Bullous Pemphigoid as an Adverse Reaction to Pembrolizumab: Two Case Reports

Kenneth Thomsen, J.E.F. Diernaes, Trine Heide Øllegaard et al. · Case Reports in Dermatology · 2018 · 21 citations · Full text

Checkpoint Inhibitors, Medicine, Melanoma +12

Increased Soluble PD-1 Predicts Response to Nivolumab plus Ipilimumab in Melanoma

Jesper Pedersen, Mateo Sokač, Boe Sandahl Sørensen et al. · Cancers · 2022 · 19 citations · Full text